1 | insulin | 24,961 |
2 | multidrug | 512 |
3 | methicillin | 172 |
4 | multi-drug | 163 |
5 | assessment-insulin | 82 |
6 | insulin-glucose | 18 |
7 | lvx | 14 |
8 | myxovirus | 12 |
9 | moderate-volume | 11 |
10 | apramycin | 10 |
11 | 2-mercaptoethanol | 8 |
12 | 'insulin | 6 |
13 | beta-lactamase-mediated | 6 |
14 | homa-insulin | 6 |
15 | multixenobiotic | 6 |
16 | akt/glut4 | 5 |
17 | antihormone | 5 |
18 | curcumol | 5 |
19 | dual-class | 5 |
20 | multidrug- | 5 |
21 | antiplasmin | 4 |
22 | penta-one | 4 |
23 | s-insulin | 4 |
24 | α-granule | 4 |
25 | abpm-confirmed | 3 |
26 | fusariosis | 3 |
27 | hygb | 3 |
28 | met-mediated | 3 |
29 | mlsb | 3 |
30 | multiple-antibiotic | 3 |
31 | pan-drug | 3 |
32 | 'assay | 2 |
33 | 2-insulin | 2 |
34 | alcator | 2 |
35 | anti-egfr-targeted | 2 |
36 | anti-multidrug | 2 |
37 | anti-nicotinic | 2 |
38 | beta-amylase | 2 |
39 | cnp-induced | 2 |
40 | cortisol-time | 2 |
41 | cu/a-ta2o5/pt | 2 |
42 | cxcl12-mediated | 2 |
43 | epinephrine-insulin | 2 |
44 | fruit-rot | 2 |
45 | hepatic-insulin | 2 |
46 | hyperinsulinemia/insulin | 2 |
47 | immediate-postoperative | 2 |
48 | insulin-glp-1 | 2 |
49 | insulin/insulin | 2 |
50 | lamivudine-associated | 2 |
51 | macrolide-lincosamide | 2 |
52 | non-perfusion | 2 |
53 | nonperiodized | 2 |
54 | pandrug | 2 |
55 | pinprick/cold | 2 |
56 | pre-cementation | 2 |
57 | protaminated | 2 |
58 | schiffair | 2 |
59 | sendoglin | 2 |
60 | speedo | 2 |
61 | stress-hormone | 2 |
62 | t39-induced | 2 |
63 | toyocamycin | 2 |
64 | vertex-wise | 2 |
65 | well-thought-out | 2 |
66 | wild-type-gh | 2 |
67 | 'antiplatelet | 1 |
68 | +3×insulin | 1 |
69 | -/elicitor-mediated | 1 |
70 | -17b | 1 |
71 | /insulin | 1 |
72 | /multidrug | 1 |
73 | 0.1.02.2008 | 1 |
74 | 0.13+/-0.04 | 1 |
75 | 190x | 1 |
76 | 310-fold-decreased | 1 |
77 | 5ht1a-receptor | 1 |
78 | a62v | 1 |
79 | abpc/cpz | 1 |
80 | alpha-cell | 1 |
81 | amylose-associated | 1 |
82 | analysis-insulin | 1 |
83 | aneurysm/dyskinesis | 1 |
84 | antibimicrobial | 1 |
85 | apl-dependent | 1 |
86 | approximately/purulent | 1 |
87 | arearatio | 1 |
88 | avr3-dependent | 1 |
89 | beta-lactamase-induced | 1 |
90 | bmi/insulin | 1 |
91 | boc-associated | 1 |
92 | body-scaled | 1 |
93 | brassinazole | 1 |
94 | breast-level | 1 |
95 | bromoxynil | 1 |
96 | castration- | 1 |
97 | cbia-derived | 1 |
98 | cddp-acquired | 1 |
99 | chemoantibiotic | 1 |
100 | chloramphenicol/florfenicol | 1 |
101 | circuit-type | 1 |
102 | colour-contrast | 1 |
103 | concentration-to-weight-adjusted | 1 |
104 | crpplus | 1 |
105 | drug/parasite | 1 |
106 | dynamics-based | 1 |
107 | ecc-only | 1 |
108 | efflux-mediated | 1 |
109 | epirubicin-mediated | 1 |
110 | fibre-type | 1 |
111 | field-selected | 1 |
112 | function/insulin | 1 |
113 | glar+met+insulin | 1 |
114 | glucagone | 1 |
115 | gnrh-gonadotropin | 1 |
116 | heat-cold | 1 |
117 | heavy-slow | 1 |
118 | hi-maize | 1 |
119 | hiv-drug | 1 |
120 | hiv-reservoirs | 1 |
121 | hyperinsulinaemia/insulin | 1 |
122 | hypertrophy-traditional | 1 |
123 | hypertrophy-type | 1 |
124 | i-3-dependent | 1 |
125 | inaccessible-solid | 1 |
126 | index-insulin | 1 |
127 | inflammation/insulin | 1 |
128 | insulin+insulin | 1 |
129 | intolerance/insulin | 1 |
130 | jev-induced | 1 |
131 | jq1 | 1 |
132 | kapitza | 1 |
133 | l-mediated | 1 |
134 | level-targeted | 1 |
135 | lox-3-null/preharvest | 1 |
136 | m-leptin | 1 |
137 | methicillin-oxacillin | 1 |
138 | mixovirus | 1 |
139 | mrp-mediated | 1 |
140 | mtk-induced | 1 |
141 | mulitdrug | 1 |
142 | multi-antibiotic | 1 |
143 | multidrug/xenobiotic | 1 |
144 | mutation-based | 1 |
145 | mutation-mediated | 1 |
146 | mycorrhizal-induced | 1 |
147 | nalidixic/ciprofloxacin | 1 |
148 | napthalophos | 1 |
149 | nes+t | 1 |
150 | non-multi-drug | 1 |
151 | non-multidrug | 1 |
152 | non-mutational | 1 |
153 | non-temperature | 1 |
154 | nonsulfonylurea | 1 |
155 | obesity/insulin | 1 |
156 | ogtt-insulin | 1 |
157 | pacing-system | 1 |
158 | parental/cisplatin | 1 |
159 | patient-group-specific | 1 |
160 | peni-g | 1 |
161 | penicillin/macrolide | 1 |
162 | peptide-hormone | 1 |
163 | ph-3-mediated | 1 |
164 | platinum-drug | 1 |
165 | polymyxin-only | 1 |
166 | portocollateral | 1 |
167 | potassium-based | 1 |
168 | pre-cck | 1 |
169 | pre-glomerular | 1 |
170 | prognosis/drug | 1 |
171 | prostatec | 1 |
172 | quinolon | 1 |
173 | radiation-acquired | 1 |
174 | relocalized | 1 |
175 | retrovesicular | 1 |
176 | serum/nasal | 1 |
177 | shv-18 | 1 |
178 | superslow | 1 |
179 | symbiont-conferred | 1 |
180 | tnfalpha-stimulated | 1 |
181 | trancheobronchial | 1 |
182 | transport-based | 1 |
183 | trichome-based | 1 |
184 | trimethoprim/ciprofloxacin | 1 |
185 | trypsinase | 1 |
186 | univariate/threshold | 1 |
187 | unused-ett | 1 |
188 | urine-ic | 1 |
189 | used-ett | 1 |
190 | uvb-erythemal | 1 |
191 | vitro-developed | 1 |
192 | β-lactam-associated | 1 |
193 | ▾insulin | 1 |
1 | 'antiplatelet | 1 |
2 | 'assay | 2 |
3 | 'insulin | 6 |
4 | +3×insulin | 1 |
5 | -/elicitor-mediated | 1 |
6 | -17b | 1 |
7 | /insulin | 1 |
8 | /multidrug | 1 |
9 | 0.1.02.2008 | 1 |
10 | 0.13+/-0.04 | 1 |
11 | 190x | 1 |
12 | 2-insulin | 2 |
13 | 2-mercaptoethanol | 8 |
14 | 310-fold-decreased | 1 |
15 | 5ht1a-receptor | 1 |
16 | a62v | 1 |
17 | abpc/cpz | 1 |
18 | abpm-confirmed | 3 |
19 | akt/glut4 | 5 |
20 | alcator | 2 |
21 | alpha-cell | 1 |
22 | amylose-associated | 1 |
23 | analysis-insulin | 1 |
24 | aneurysm/dyskinesis | 1 |
25 | anti-egfr-targeted | 2 |
26 | anti-multidrug | 2 |
27 | anti-nicotinic | 2 |
28 | antibimicrobial | 1 |
29 | antihormone | 5 |
30 | antiplasmin | 4 |
31 | apl-dependent | 1 |
32 | approximately/purulent | 1 |
33 | apramycin | 10 |
34 | arearatio | 1 |
35 | assessment-insulin | 82 |
36 | avr3-dependent | 1 |
37 | beta-amylase | 2 |
38 | beta-lactamase-induced | 1 |
39 | beta-lactamase-mediated | 6 |
40 | bmi/insulin | 1 |
41 | boc-associated | 1 |
42 | body-scaled | 1 |
43 | brassinazole | 1 |
44 | breast-level | 1 |
45 | bromoxynil | 1 |
46 | castration- | 1 |
47 | cbia-derived | 1 |
48 | cddp-acquired | 1 |
49 | chemoantibiotic | 1 |
50 | chloramphenicol/florfenicol | 1 |
51 | circuit-type | 1 |
52 | cnp-induced | 2 |
53 | colour-contrast | 1 |
54 | concentration-to-weight-adjusted | 1 |
55 | cortisol-time | 2 |
56 | crpplus | 1 |
57 | cu/a-ta2o5/pt | 2 |
58 | curcumol | 5 |
59 | cxcl12-mediated | 2 |
60 | drug/parasite | 1 |
61 | dual-class | 5 |
62 | dynamics-based | 1 |
63 | ecc-only | 1 |
64 | efflux-mediated | 1 |
65 | epinephrine-insulin | 2 |
66 | epirubicin-mediated | 1 |
67 | fibre-type | 1 |
68 | field-selected | 1 |
69 | fruit-rot | 2 |
70 | function/insulin | 1 |
71 | fusariosis | 3 |
72 | glar+met+insulin | 1 |
73 | glucagone | 1 |
74 | gnrh-gonadotropin | 1 |
75 | heat-cold | 1 |
76 | heavy-slow | 1 |
77 | hepatic-insulin | 2 |
78 | hi-maize | 1 |
79 | hiv-drug | 1 |
80 | hiv-reservoirs | 1 |
81 | homa-insulin | 6 |
82 | hygb | 3 |
83 | hyperinsulinaemia/insulin | 1 |
84 | hyperinsulinemia/insulin | 2 |
85 | hypertrophy-traditional | 1 |
86 | hypertrophy-type | 1 |
87 | i-3-dependent | 1 |
88 | immediate-postoperative | 2 |
89 | inaccessible-solid | 1 |
90 | index-insulin | 1 |
91 | inflammation/insulin | 1 |
92 | insulin | 24,961 |
93 | insulin+insulin | 1 |
94 | insulin-glp-1 | 2 |
95 | insulin-glucose | 18 |
96 | insulin/insulin | 2 |
97 | intolerance/insulin | 1 |
98 | jev-induced | 1 |
99 | jq1 | 1 |
100 | kapitza | 1 |
101 | l-mediated | 1 |
102 | lamivudine-associated | 2 |
103 | level-targeted | 1 |
104 | lox-3-null/preharvest | 1 |
105 | lvx | 14 |
106 | m-leptin | 1 |
107 | macrolide-lincosamide | 2 |
108 | met-mediated | 3 |
109 | methicillin | 172 |
110 | methicillin-oxacillin | 1 |
111 | mixovirus | 1 |
112 | mlsb | 3 |
113 | moderate-volume | 11 |
114 | mrp-mediated | 1 |
115 | mtk-induced | 1 |
116 | mulitdrug | 1 |
117 | multi-antibiotic | 1 |
118 | multi-drug | 163 |
119 | multidrug | 512 |
120 | multidrug- | 5 |
121 | multidrug/xenobiotic | 1 |
122 | multiple-antibiotic | 3 |
123 | multixenobiotic | 6 |
124 | mutation-based | 1 |
125 | mutation-mediated | 1 |
126 | mycorrhizal-induced | 1 |
127 | myxovirus | 12 |
128 | nalidixic/ciprofloxacin | 1 |
129 | napthalophos | 1 |
130 | nes+t | 1 |
131 | non-multi-drug | 1 |
132 | non-multidrug | 1 |
133 | non-mutational | 1 |
134 | non-perfusion | 2 |
135 | non-temperature | 1 |
136 | nonperiodized | 2 |
137 | nonsulfonylurea | 1 |
138 | obesity/insulin | 1 |
139 | ogtt-insulin | 1 |
140 | pacing-system | 1 |
141 | pan-drug | 3 |
142 | pandrug | 2 |
143 | parental/cisplatin | 1 |
144 | patient-group-specific | 1 |
145 | peni-g | 1 |
146 | penicillin/macrolide | 1 |
147 | penta-one | 4 |
148 | peptide-hormone | 1 |
149 | ph-3-mediated | 1 |
150 | pinprick/cold | 2 |
151 | platinum-drug | 1 |
152 | polymyxin-only | 1 |
153 | portocollateral | 1 |
154 | potassium-based | 1 |
155 | pre-cck | 1 |
156 | pre-cementation | 2 |
157 | pre-glomerular | 1 |
158 | prognosis/drug | 1 |
159 | prostatec | 1 |
160 | protaminated | 2 |
161 | quinolon | 1 |
162 | radiation-acquired | 1 |
163 | relocalized | 1 |
164 | retrovesicular | 1 |
165 | s-insulin | 4 |
166 | schiffair | 2 |
167 | sendoglin | 2 |
168 | serum/nasal | 1 |
169 | shv-18 | 1 |
170 | speedo | 2 |
171 | stress-hormone | 2 |
172 | superslow | 1 |
173 | symbiont-conferred | 1 |
174 | t39-induced | 2 |
175 | tnfalpha-stimulated | 1 |
176 | toyocamycin | 2 |
177 | trancheobronchial | 1 |
178 | transport-based | 1 |
179 | trichome-based | 1 |
180 | trimethoprim/ciprofloxacin | 1 |
181 | trypsinase | 1 |
182 | univariate/threshold | 1 |
183 | unused-ett | 1 |
184 | urine-ic | 1 |
185 | used-ett | 1 |
186 | uvb-erythemal | 1 |
187 | vertex-wise | 2 |
188 | vitro-developed | 1 |
189 | well-thought-out | 2 |
190 | wild-type-gh | 2 |
191 | α-granule | 4 |
192 | β-lactam-associated | 1 |
193 | ▾insulin | 1 |
1 | multidrug- | 5 |
2 | castration- | 1 |
3 | insulin-glp-1 | 2 |
4 | jq1 | 1 |
5 | 0.13+/-0.04 | 1 |
6 | akt/glut4 | 5 |
7 | 0.1.02.2008 | 1 |
8 | shv-18 | 1 |
9 | nonsulfonylurea | 1 |
10 | kapitza | 1 |
11 | -17b | 1 |
12 | hygb | 3 |
13 | mlsb | 3 |
14 | prostatec | 1 |
15 | urine-ic | 1 |
16 | patient-group-specific | 1 |
17 | anti-nicotinic | 2 |
18 | multiple-antibiotic | 3 |
19 | multi-antibiotic | 1 |
20 | chemoantibiotic | 1 |
21 | multidrug/xenobiotic | 1 |
22 | multixenobiotic | 6 |
23 | t39-induced | 2 |
24 | beta-lactamase-induced | 1 |
25 | mtk-induced | 1 |
26 | mycorrhizal-induced | 1 |
27 | cnp-induced | 2 |
28 | jev-induced | 1 |
29 | body-scaled | 1 |
30 | abpm-confirmed | 3 |
31 | vitro-developed | 1 |
32 | radiation-acquired | 1 |
33 | cddp-acquired | 1 |
34 | symbiont-conferred | 1 |
35 | trichome-based | 1 |
36 | potassium-based | 1 |
37 | mutation-based | 1 |
38 | dynamics-based | 1 |
39 | transport-based | 1 |
40 | 310-fold-decreased | 1 |
41 | boc-associated | 1 |
42 | lamivudine-associated | 2 |
43 | amylose-associated | 1 |
44 | β-lactam-associated | 1 |
45 | cxcl12-mediated | 2 |
46 | ph-3-mediated | 1 |
47 | beta-lactamase-mediated | 6 |
48 | l-mediated | 1 |
49 | epirubicin-mediated | 1 |
50 | mutation-mediated | 1 |
51 | mrp-mediated | 1 |
52 | -/elicitor-mediated | 1 |
53 | met-mediated | 3 |
54 | efflux-mediated | 1 |
55 | tnfalpha-stimulated | 1 |
56 | protaminated | 2 |
57 | field-selected | 1 |
58 | level-targeted | 1 |
59 | anti-egfr-targeted | 2 |
60 | concentration-to-weight-adjusted | 1 |
61 | cbia-derived | 1 |
62 | nonperiodized | 2 |
63 | relocalized | 1 |
64 | inaccessible-solid | 1 |
65 | heat-cold | 1 |
66 | pinprick/cold | 2 |
67 | univariate/threshold | 1 |
68 | penicillin/macrolide | 1 |
69 | macrolide-lincosamide | 2 |
70 | brassinazole | 1 |
71 | α-granule | 4 |
72 | cortisol-time | 2 |
73 | moderate-volume | 11 |
74 | penta-one | 4 |
75 | glucagone | 1 |
76 | peptide-hormone | 1 |
77 | stress-hormone | 2 |
78 | antihormone | 5 |
79 | fibre-type | 1 |
80 | circuit-type | 1 |
81 | hypertrophy-type | 1 |
82 | non-temperature | 1 |
83 | beta-amylase | 2 |
84 | trypsinase | 1 |
85 | vertex-wise | 2 |
86 | insulin-glucose | 18 |
87 | drug/parasite | 1 |
88 | immediate-postoperative | 2 |
89 | hi-maize | 1 |
90 | peni-g | 1 |
91 | multi-drug | 163 |
92 | non-multi-drug | 1 |
93 | platinum-drug | 1 |
94 | pan-drug | 3 |
95 | hiv-drug | 1 |
96 | prognosis/drug | 1 |
97 | multidrug | 512 |
98 | anti-multidrug | 2 |
99 | non-multidrug | 1 |
100 | /multidrug | 1 |
101 | pandrug | 2 |
102 | mulitdrug | 1 |
103 | wild-type-gh | 2 |
104 | pre-cck | 1 |
105 | antibimicrobial | 1 |
106 | trancheobronchial | 1 |
107 | uvb-erythemal | 1 |
108 | non-mutational | 1 |
109 | hypertrophy-traditional | 1 |
110 | portocollateral | 1 |
111 | serum/nasal | 1 |
112 | breast-level | 1 |
113 | bromoxynil | 1 |
114 | alpha-cell | 1 |
115 | chloramphenicol/florfenicol | 1 |
116 | curcumol | 5 |
117 | 2-mercaptoethanol | 8 |
118 | pacing-system | 1 |
119 | nalidixic/ciprofloxacin | 1 |
120 | trimethoprim/ciprofloxacin | 1 |
121 | toyocamycin | 2 |
122 | apramycin | 10 |
123 | sendoglin | 2 |
124 | methicillin-oxacillin | 1 |
125 | methicillin | 172 |
126 | insulin | 24,961 |
127 | 'insulin | 6 |
128 | insulin+insulin | 1 |
129 | glar+met+insulin | 1 |
130 | 2-insulin | 2 |
131 | homa-insulin | 6 |
132 | hepatic-insulin | 2 |
133 | epinephrine-insulin | 2 |
134 | s-insulin | 4 |
135 | analysis-insulin | 1 |
136 | assessment-insulin | 82 |
137 | ogtt-insulin | 1 |
138 | index-insulin | 1 |
139 | /insulin | 1 |
140 | hyperinsulinaemia/insulin | 1 |
141 | hyperinsulinemia/insulin | 2 |
142 | intolerance/insulin | 1 |
143 | bmi/insulin | 1 |
144 | insulin/insulin | 2 |
145 | inflammation/insulin | 1 |
146 | function/insulin | 1 |
147 | obesity/insulin | 1 |
148 | +3×insulin | 1 |
149 | ▾insulin | 1 |
150 | antiplasmin | 4 |
151 | gnrh-gonadotropin | 1 |
152 | parental/cisplatin | 1 |
153 | m-leptin | 1 |
154 | non-perfusion | 2 |
155 | pre-cementation | 2 |
156 | quinolon | 1 |
157 | speedo | 2 |
158 | arearatio | 1 |
159 | retrovesicular | 1 |
160 | pre-glomerular | 1 |
161 | schiffair | 2 |
162 | alcator | 2 |
163 | 5ht1a-receptor | 1 |
164 | aneurysm/dyskinesis | 1 |
165 | fusariosis | 3 |
166 | napthalophos | 1 |
167 | hiv-reservoirs | 1 |
168 | dual-class | 5 |
169 | crpplus | 1 |
170 | mixovirus | 1 |
171 | myxovirus | 12 |
172 | nes+t | 1 |
173 | 'antiplatelet | 1 |
174 | i-3-dependent | 1 |
175 | avr3-dependent | 1 |
176 | apl-dependent | 1 |
177 | approximately/purulent | 1 |
178 | fruit-rot | 2 |
179 | cu/a-ta2o5/pt | 2 |
180 | colour-contrast | 1 |
181 | lox-3-null/preharvest | 1 |
182 | used-ett | 1 |
183 | unused-ett | 1 |
184 | well-thought-out | 2 |
185 | a62v | 1 |
186 | heavy-slow | 1 |
187 | superslow | 1 |
188 | 190x | 1 |
189 | lvx | 14 |
190 | 'assay | 2 |
191 | ecc-only | 1 |
192 | polymyxin-only | 1 |
193 | abpc/cpz | 1 |